Martin Marietta Materials, Inc. (NYSE:MLM) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On July 15, 2019, the board of directors (the “Board”) of Martin Marietta Materials, Inc. (the “Company”) increased the size of the Board from 9 directors to 10 directors and elected Thomas H. Pike to fill the newly-created directorship. Mr. Pike has been appointed to the Board’s Management Development and Compensation Committee.

Mr. Pike will receive the director fees and stock-based compensation for directors previously disclosed in the Company’s proxy statement for its 2019 Annual Meeting of Shareholders. Mr. Pike will stand for re-election at the Company’s 2020 Annual Meeting of Shareholders.

Mr. Pike, 59, has 30 years of experience spanning a variety of industries and leading companies. He was most recently CEO and a member of the Board of Directors of Quintiles Transnational Holdings, Inc. (“Quintiles”), a leading fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, before its merger with IMS Health (NYSE: IQV) in December 2016. Mr. Pike led Quintiles through a successful public offering and helped it grow into a Fortune 500 company. Under Mr. Pike’s leadership, Quintiles was named one of the world’s Most Ethical Companies in 2016. He retired on December 1, 2016 after Quintiles’ merger with IMS Health. Prior to Quintiles, Mr. Pike spent 22 years at Accenture (NYSE: ACN), a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations, until December 2009. At Accenture, Mr. Pike’s roles included serving as Chief Risk Officer and Managing Director of the North America Health and Products business areas. Prior to that, he was the global Chief Operating Officer for Accenture’s Resources operating group and had also served as Accenture’s Chief Strategy Officer. Since leaving Accenture in December 2009 and until joining Quintiles in April 2012, Mr. Pike was involved with a number of start-ups in the technology and healthcare sectors. Early in his career, he was a consultant at McKinsey & Company.

Mr. Pike earned his bachelor of science in accounting at the University of Delaware.

There are no arrangements or understandings between Mr. Pike and any other persons to which he was selected as a director. Mr. Pike does not have a direct or indirect material interest in any transaction required to be disclosed to Item 404(a) of Regulation S-K.

A copy of the Company’s press release dated July 15, 2019 announcing the election of Mr. Pike to the Board is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

ITEM 9.01. Financial Statements and Exhibits.

MARTIN MARIETTA MATERIALS INC Exhibit
EX-99.1 2 ex99-1.htm PRESS RELEASE Exhibit 99.1     MARTIN MARIETTA APPOINTS NEW MEMBER TO BOARD OF DIRECTORS   Raleigh,…
To view the full exhibit click here

About Martin Marietta Materials, Inc. (NYSE:MLM)

Martin Marietta Materials, Inc. is a supplier of aggregates products (crushed stone, sand and gravel) for the construction industry, used for the construction of infrastructure, non-residential, and residential projects. The Company operates through three businesses: Aggregates Business, Cement Business and Magnesia Specialties Business. The Company conducts its Aggregates business through three segments: the Mid-America Group, Southeast Group, and West Group. The Company’s Cement business operates through the Cement segment. The Company’s Magnesia Specialties segment includes its magnesia-based chemicals and dolomitic lime businesses. Its Aggregates Business is engaged in mining, processing and selling granite, limestone, sand, gravel and other aggregate products. Its Cement business is engaged in producing Portland and specialty cements. In addition, aggregates products are used for railroad ballast and in agricultural, utility and environmental applications.